Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.61 USD | -1.91% | -3.33% | -36.65% |
Apr. 23 | Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 | MT |
Apr. 18 | AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management | CI |
Financials (USD)
Sales 2024 * | 461M | Sales 2025 * | 526M | Capitalization | 1.09B |
---|---|---|---|---|---|
Net income 2024 * | -34M | Net income 2025 * | -27M | EV / Sales 2024 * | 2.24 x |
Net cash position 2024 * | 61.14M | Net cash position 2025 * | 78.13M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
-30.8
x | P/E ratio 2025 * |
-39.5
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on AtriCure, Inc.
1 day | -1.91% | ||
1 week | -3.33% | ||
Current month | -25.67% | ||
1 month | -19.85% | ||
3 months | -32.51% | ||
6 months | -34.14% | ||
Current year | -36.65% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 509 M€ | -.--% | ||
0.03% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 22.61 | -1.91% | 326,848 |
24-04-24 | 23.05 | -0.52% | 419,955 |
24-04-23 | 23.17 | +2.03% | 947,750 |
24-04-22 | 22.71 | -2.11% | 684,150 |
24-04-19 | 23.2 | -0.81% | 470,018 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.65% | 1.12B | |
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+2.95% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+12.35% | 25.66B |
- Stock Market
- Equities
- ATRC Stock